Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar 12;96(5):828-31.
doi: 10.1038/sj.bjc.6603628. Epub 2007 Feb 20.

Gender differences in colorectal cancer: implications for age at initiation of screening

Affiliations

Gender differences in colorectal cancer: implications for age at initiation of screening

H Brenner et al. Br J Cancer. .

Abstract

There is some variation regarding age at initiation of screening for colorectal cancer (CRC) between countries, but the same age of initiation is generally recommended for women and men within countries, despite important gender differences in the epidemiology of CRC. We have explored whether, and to what extent, these differences would be relevant regarding age at initiation of CRC screening. Using population-based cancer registry data from the US and national mortality statistics from different countries, we looked at cumulative 10-year incidence and mortality of CRC reached among men at ages 50, 55, and 60, and found that women mainly reached equivalent levels when 4 to 8 years older. The gender differences were remarkably constant across populations and over time. These patterns suggest that gender differentiation of age at initiation may be worthwhile to utilise CRC-screening resources more efficiently.

PubMed Disclaimer

Figures

Figure 1
Figure 1
10-year cumulative incidence of colorectal cancer in subsequent 10 years among men and women at various ages. The dotted lines indicate the age differences at comparable levels of cumulative incidence between women and men. SEER Program, US, 17 registries, 2000–2003 (Ries et al, 2006).
Figure 2
Figure 2
10-year cumulative mortality from CRC in subsequent 10 years among men and women at various ages. The dotted lines indicate the age differences at comparable levels of cumulative mortality between women and men. US national mortality statistics, 2000–2003 (Ries et al, 2006).

References

    1. Beral V, Banks E, Reeves G (2002) Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 360: 942–944 - PubMed
    1. Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419–427 - PubMed
    1. Bonithon-Kopp C, Benhamiche AM (1999) Are there several colorectal cancers? Epidemiological data. Eur J Cancer Prev 8(Suppl 1): S3–S12 - PubMed
    1. Bossard N, Velten M, Remontet L, Belot A, Maarouf N, Bouvier AM, Guizard AV, Tretarre B, Launoy G, Colonna M, Danzon A, Molinie F, Troussard X, Bourdon-Raverdy N, Carli PM, Jaffre A, Bessaguet C, Sauleau E, Schvartz C, Arveux P, Maynadie M, Grosclaude P, Estève J, Faivre J (2007) Survival of cancer patients in France: The population-based study from the Association of the French Cancer Registries study'. Eur J Cancer 43: 149–160 - PubMed
    1. Brenner H, Gefeller O, Greenland S (1993) Risk and rate advancement periods as measures of exposure impact on the occurrence of chronic diseases. Epidemiology 4: 229–236 - PubMed